Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou(Université de Montpellier), P. Rougier(Université de Versailles Saint-Quentin-en-Yvelines), P Lasser(CHU Dijon Bourgogne), Laurent Bedenne(CHU Dijon Bourgogne), Valérie Boige(Inserm), Jean‐Pierre Pignon(Inserm), Olivier Bouché(CHU Dijon Bourgogne), B. Saint‐Aubert(CHU Dijon Bourgogne), Jean-Michel Fabre(CHU Dijon Bourgogne), Muriel Ducourtieux(CHU Dijon Bourgogne), Jean Genève(Northern General Hospital), G. Lebreton(CHU Dijon Bourgogne), Thierry Conroy(Inserm)
Cited by 2,096
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2010|1.9k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k